🎉 Intestinal Research has achieved a 2025 Impact Factor of 4.7 and advanced to Q1 in the Gastroenterology & Hepatology category!
A heartfelt thank you to our authors, reviewers, editorial board members, and readers for your continued support.
Rapid diagnosis and therapeutic mitigation in inflammatory bowel disease: utilizing the window of opportunity–findings from the UAE Epi-IBD study
https://t.co/r705rp1ZXI
Incidence and treatment-based risk stratification of opportunistic infections in patients with inflammatory bowel disease: an ambispective cohort study in Brazil
https://t.co/dcdK5Nk2hf
Guselkumab efficacy and safety in East Asian participants with moderately to severely active Crohn’s disease: subgroup analysis of the phase 3 GALAXI 2 and GALAXI 3 trials
https://t.co/yHeyfE59Z9
Transabdominal intestinal ultrasound parameters as intermediate treatment targets in a treat-to-target strategy for moderate-to-severe ulcerative colitis
https://t.co/sSoXLBfR71
Appropriate J-pouch volume associated with improved clinical outcomes and long-term quality of life in patients with ulcerative colitis after ileal pouch-anal anastomosis: results from China UC Pouch Center Union
https://t.co/qCIDxnWN2u
One-year effectiveness and safety of ustekinumab treatment in patients with ulcerative colitis: an Asan-Crohn’s and Colitis Association in Daegu-Gyeongbuk (CCAiD) multicenter real-world cohort study
https://t.co/recoJdqH10
Practices and perceptions of imaging assessment in inflammatory bowel disease: a nationwide survey of physicians in Korea by KASID Guidelines Taskforce Team
https://t.co/s9xHxpgQFW
Clinical usefulness of fecal calprotectin in assessing disease activity and endoscopic remission in intestinal Behçet’s disease
https://t.co/YDvFNxLtwB
Impact of filgotinib on health-related quality of life over 3 years in Japanese patients with ulcerative colitis: a post hoc analysis of the SELECTION and SELECTION long-term extension trials
https://t.co/jrP49wMycy
Efficacy and safety of mirikizumab in maintenance therapy for ulcerative colitis in difficult-to-treat inflammatory bowel disease: a single-center retrospective study in Japan
https://t.co/cED80Ak5Ay